Oncotarget, established in 2010, has provided the scientists and researchers with a platform to publish their research article.
The Journal is a peer-review journal, and that is what makes it unique. Other experienced scientists. Review the different research papers before they are published.
Impact Journals publishes Journal. Experienced and skilled researchers manage the Journal, and that is the reason for the success. The Editors-in-chief are Andrei V. Gudkov and Mikhail Blagosklonny from the Roswell Park Cancer Institute. Download output styles at Endnote.com.
Oncotarget is an open Journal and thus means that the public can easily access new content every week. The primary role of the Journal is to help the authors increase the impact and the value of the research.
Two of the members of Editorial Board; Carlo M Croce, the former Editor-in-Chief of Cancer Research and the Andrew Schally, published 27 articles and ten articles respectively.
Since its inception, four of the Oncotarget members win the Breakthrough Prize, which is the highest award.
The Journal is licensed under the Creative Commons Attribution 3.0 license. The Gordon Research Conference is the official sponsors of the Journal. The Journal seeks to promote a life without diseases. The scientists foster research on basic clinical science to help in fighting diseases.
The Journal is focused on the research on cancer and oncology. However, they also publish other health-related research papers including cardiology, metabolism, cell biology, endocrinology, and pharmacology. It is important for researchers to indicate the category of the research paper.
The Journal adheres to strict submission guidelines. They support different type of papers like research papers and editorial news. The paper editorial news should have a minimum of 800 words. The references should also be one page. It is required for scientists to include a maximum of three co-editors.
There is no limit on the number of website and references that can be included. The publishing fee is $ 3.400. As of February 2017, the fee is $2,850. The editorial team also gives discounts like $1,900 to respective research. There are no refunds given once the fist manuscript has been published. Read more about Oncotarget at Google Scholar.